Phosphorylation of the androgen receptor (AR) hinge and ligand-binding sites by GSK3β has been reported to inhibit expression of AR gene targets, thus inhibiting androgen-dependent prostate cancer cell proliferation [24, 25]. This evidence concerns the gene AR and prostate carcinoma.